Vitalzym
En vente sur le marché américain (selon le DSLD)
World Nutrition, food supplement from the US market
Vitalzym (World Nutrition), a food supplement au code-barres 805034652153, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- World Nutrition
- Barcode
- 805034652153
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Medium Chain Triglyceride, Starch, Glycerin, Polysaccharide, Coating, Beeswax, Glycerin Fatty Acid Ester, Lecithin, Citric Acid
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Enzyme Blend | Blend | 168 mg |
| Bromelain | Enzyme | not stated |
| Papain | Enzyme | not stated |
| Rutin | Other substance | not stated |
| Amylase | Enzyme | not stated |
| Protease | Enzyme | not stated |
| Lipase | Enzyme | not stated |
| Amla (Phyllanthus emblica) | Plant | not stated |
| Serrapeptase | Enzyme | not stated |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Vitalzym
Entered into DSLD on 25 April 2018. Retirée du marché américain le 19 March 2024 (selon le DSLD).- Same quantity, different name: Serratiopeptidase in this version; Serrapeptase on the displayed label (quantity not stated)
- Different quantity per serving : Proprietary Enzyme Blend: 166 mg in this version; 168 mg on the displayed label
Official label: Vitalzym
Entered into DSLD on 25 March 2013. En vente sur le marché américain (selon le DSLD).- Active ingredient removed : Amla (quantity not stated)
- Active ingredient removed : Amylase (quantity not stated)
- Active ingredient removed : Bromelain (quantity not stated)
- Active ingredient removed : Lipase (quantity not stated)
- Active ingredient removed : Papain (quantity not stated)
- Active ingredient removed : Protease (quantity not stated)
- Active ingredient removed : Rutin (quantity not stated)
- Active ingredient removed : Serrapeptase (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Rutin
Read the warning, when it applies and the studies cited
RUTIN
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (PDR 2008).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Amla
Read the warning, when it applies and the studies cited
Amla - Phyllanthus Emblica
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (HC 2009).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 3 grams of amla, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (HC 2009).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Amlapitta, Digestive tonic.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Laxative.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (HC 2009; Pray 2006; CPhA 2002).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Laxative.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (HC 2009).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: Amlapitta, Antioxidant, Digestive tonic, Rasayana or Eye tonic.
When using this product you may experience a laxative effect.
- Serrapeptase
Read the warning, when it applies and the studies cited
SERRAPEPTASE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gastrointestinal lesions/ulcers, a kidney or liver disorder, or are having surgery (Bhagat et al. 2013; Chopra et al. 2009; Al- Khateeb and Nusair 2008; Mazzone et al. 1990).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or anti-inflammatory medications (Bhagat et al. 2013; Chopra et al. 2009; Al-Khateeb and Nusair 2008; Mazzone et al. 1990).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if rash, difficulty breathing, hypersensitivity and/or severe allergy occur (Bhagat et al. 2013; Balagi 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : World Nutrition
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.